Longitudinal Patient Reported Outcomes with CAR-T Cell Therapy Versus Autologous and Allogeneic Stem Cell Transplant
Open Access
- 9 May 2022
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 28 (8) , 473-482
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Pfizer
- Celgene
- Spectrum Pharmaceuticals
- Mayo Clinic (2K12CA090628-21)
- American Society of Clinical Oncology (KL2TR003143)
- Janssen Pharmaceutica
- Bristol-Myers Squibb
- Mayo Foundation for Medical Education and Research
- National Cancer Institute
- AbbVie
- Takeda Pharmaceutical Company
This publication has 26 references indexed in Scilit:
- Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254The Lancet Oncology, 2016
- Evaluating Individual Change With the Quality of Life in Neurological Disorders (Neuro-QoL) Short FormsArchives of Physical Medicine and Rehabilitation, 2016
- Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized TrialsJournal of Clinical Oncology, 2015
- Chimeric Antigen Receptor T Cells for Sustained Remissions in LeukemiaNew England Journal of Medicine, 2014
- Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)JNCI: Journal of the National Cancer Institute, 2014
- Cognition assessment using the NIH ToolboxNeurology, 2013
- Neuro-QOLNeurology, 2012
- Meta-analysis provides evidence-based interpretation guidelines for the clinical significance of mean differences for the FACT-G, a cancer-specific quality of life questionnairePatient Related Outcome Measures, 2010
- Changes in Quality-of-Life and Psychosocial Adjustment among Multiple Myeloma Patients Treated with High-Dose Melphalan and Autologous Stem Cell TransplantationTransplantation and Cellular Therapy, 2009
- Toxicity and response criteria of the Eastern Cooperative Oncology GroupAmerican Journal of Clinical Oncology, 1982